Sujuan Ba, Ph.D. has been awarded the Leadership Award for Global Advocate of Cancer Research by the Hong Kong Biotechnology Organization (HKBIO) at their BIOHK2023 Conference (13-16 September, Hong Kong Convention and Exhibition Centre). Dr. Ba is the President, CEO and Founder of the Asian Fund for Cancer Research, CEO…...
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Privo Technologies to Receive $900,000 of Investment Funding Privo Technologies and its chief executive officer, Manijeh Goldberg, Ph.D., have been selected as the winner of the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition, a first of its kind program for female entrepreneurs starting oncology companies. Privo Technologies has developed a nano-engineered platform…...
Arbele Presenting at the 2021 China BioMed Forum during the 39th J.P. Morgan Healthcare Conference
The Asian Fund for Cancer Research is proud to support Arbele, our finalist of the 2020 BRACE Award Competition, to present at the Virtual 2021 China BioMed Forum during the 39th J.P. Morgan Healthcare Conference. This Virtual Event will take place on January 12-13, 2021, co-hosted by our partner organization,…...
Congratulations to the Finalists of the 2020 BRACE Award Venture Competition!
The Asian Fund for Cancer Research is proud to announce the top two finalists resulting from our just-concluded 2020 BRACE Award Venture Competition: Albatroz Therapeutics Scientific Founder & CEO Frederic Bard, Ph.D., and Arbele Chief Development Officer Dennis Wong, M.D. Both companies are developing innovative technologies that could lead to life-saving…...
Congratulations to our Top Two Finalists and the People’s Choice Award Winner!
Congratulations to the inaugural AIM-HI Women’s Venture Competition finalists selected by the Judging Committee, Stacy Blain of Concarlo Holdings and Manijeh Goldberg of Privo Technologies. Not only are they advancing science, but they are also paving the way for more women scientist-entrepreneurs. The AIM-HI Women’s Venture Competition also hosted a People’s Choice…...
Support Women Scientist-Entrepreneurs in Celebration of the Women’s Equality Day
It’s 2020, and still only 2.2% of all venture capital dollars go to companies led by women entrepreneurs in life sciences. Let’s change that! Join us on Thursday, September 24, at the AIM-HI Women’s Venture Competition Award Ceremony as we celebrate 8 leading-edge women entrepreneurs, each on the cusp of developing innovative therapies…...
AIM-HI Announces Semi-Finalists in Women’s Venture Competition, Finalists Announced Sept. 24
The 8 semi-finalists are just announced in the AIM-HI Accelerator Fund’s inaugural Women’s Venture Competition! These innovative oncology startups are selected from an exceptional pool of high quality women entrepreneur applications, by a Selection Committee comprised of world-class key opinion leaders, life sciences industry experts, investors, and entrepreneurs. The Women’s…...
Infection Threat from Asymptomatic COVID-19 Patients Around You
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The recently announced extension of social distancing guidelines through the end of April is an important step taken by the U.S. federal government to slow down the spread of coronavirus. But the overall picture of the COVID-19 pandemic is still very…...
- 1
- 2